Health Officials Worry A Deadly Avian Flu In China Could Be Next Pandemic

Health workers act in an exercise dealing with an outbreak of H7N9 avian flu on June 17 in Hebi, China. (Photo: Barcroft Media via Getty Images)
Health workers act in an exercise dealing with an outbreak of H7N9 avian flu on June 17 in Hebi, China. (Photo: Barcroft Media via Getty Images)

On March 31, 2013, the Chinese health ministry quietly notified the World Heath Organization of three mysterious deaths. After developing coughing and sneezing symptoms, the victims' lungs had filled with fluid, and they died gasping for air. The only thing they had in common was being around live chickens. One victim worked at a poultry market, and the other two recently had shopped at one.

Tests revealed what global health officials had feared for decades: There was a new form of avian influenza. “This strain usually caused mild symptoms like redness of the eyes or low-grade respiratory problems in humans,” said Daniel Jernigan, head of the influenza division of the U.S. Centers for Disease Control and Prevention. “We knew it was different and much more severe when it killed three people.”

More than four years later, the virus has spread across southern China and sickened nearly 1,560 people, nearly 40 percent of whom have died. In May, the CDC ranked the influenza strain H7N9 the highest possible threat for viruses at risk of causing a worldwide pandemic ― just a year shy of the 100th anniversary of the Spanish flu outbreak that claimed nearly 50 million lives in 1918.

Although reports of new infections stopped in March, health officials are worried about the virus changing into a form that’s easily transmitted between humans. A new paper published this summer forecast the virus being three mutations away from such a reality.

“It’s slowly adapting to receptors in humans, and it can spread around the entire globe within a year by people coughing,” said Rick Bright, director of the Biomedical Advanced Research and Development Authority, the government agency in charge of medical countermeasures to national security and public health threats. By contrast, it only took about a year and a half for the 1918 pandemic to kill nearly three times as many people as died in World War I. “That’s when people were traveling on boats. The way we live now with air travel and more people in crowded cities, we could easily have a hot flash,” Bright said.

A new flu outbreak would challenge officials to develop, test, manufacture and distribute millions of doses of an influenza vaccine in time to avert mass casualties. It would also be the biggest test to date of the world’s souped-up surveillance network that has more than doubled in the last couple of decades; there are currently 140 centers in different countries that track and report virus outbreaks.

“We have to monitor this very closely because of all the viruses we have studied so far in the last 20 years, this has the highest potential to mutate to become a pandemic virus,” said Jernigan.

Although warnings of a possible flu pandemic sound terrifying, it’s still a worst-case scenario. Just as it could mutate into something more sinister, it could also become less dangerous. “It could be one of those things that we monitor effectively for the next decade or more, and it never crosses that threshold of efficiently infecting people and causing lots of sickness and death,” said Bright.

So far, the H7N9 strain hasn’t crossed the border from China, and the CDC hasn’t recommended that Americans avoid traveling there (although they should cross live chicken markets off their tour list). And the virus is frustratingly fickle. Case in point: As soon as scientists developed a vaccine for the 2013 strain to be placed into the national stockpile, the virus changed – a phenomenon known as “drift.” Now they’re trying to make another one.

Chasing the vaccine

It currently takes at least six months to produce enough vaccine to cover the U.S. population by culturing the virus in millions of chicken eggs or growing cell lines from dog kidneys. Drug companies are experimenting with other techniques, such as mapping out the virus’ genetic sequence that could shave several months off the entire process – critical days that could help avoid the fiasco of 2009, when the vaccine against the H1N1 swine flu pandemic that killed 17,000 people arrived too late.

“We’ve found ways to improve the yield from batches and figured out ways to make them faster,” said Bright, adding that the U.S. government is partnering with five pharmaceutical companies that collectively have the capacity to produce 600 million doses. (By contrast, nearly 145 million people in the U.S. are vaccinated against the seasonal flu each year.)

Health officials got a wakeup call in 2004 when an influenza strain called H5N1 spread across southeast Asia, and the George W. Bush administration launched a campaign for pandemic flu preparedness that resulted in Congress approving $5.6 billion in part to boost the nation’s drug manufacturing capacity for vaccines and stockpile anti-virals like Tamiflu to treat the sick. “We wanted to ensure our ability to protect everyone in this country and not pick and choose who were the most important,” said Bright. That was on the heels of the SARS pneumonia outbreak in 2003 that resulted in nearly 800 deaths. “We realized that if we had a severe pandemic like in 1918, we wouldn’t be prepared,” added Jernigan.

Holes in the system

Even with vaccines at the ready, the bigger problem might be distributing them using a network of state and county health agencies that are suffering from budget cuts. “How do we administer these to the entire population at once? It’s not like handing out a pill. All this takes money and people and practice, and we just don’t have that right now,” said Jennifer Nuzzo, senior associate for the Johns Hopkins Center for Health Security. “It’s that last mile that will be the hardest.” Hospitals that have lost federal funding for preparedness training might not be equipped to handle an influx of sick patients, either.

Yet the future of influenza prevention might not involve scrambling to reinvent a new vaccine against every threat. “The dream of the moment is to have a universal vaccine with antibodies that will neutralize every known influenza virus that we’ve tested so far,” said Robert Webster, who has studied influenza for 50 years and is emeritus faculty at St. Jude Children’s Research Hospital. Scientists at pharmaceutical giant Johnson & Johnson’s Janssen Vaccines have already started testing one version in mice and ferrets and hope to start the first phase of clinical trials within a year. “We will never eradicate flu, but we’d be in a better place to control it, like measles. You wouldn’t have to get a yearly flu shot,” said Webster.

Also on HuffPost

Ebola is highly infectious and even being in the same room as someone with the disease can put you at risk

Not as far as we know. <a href="http://www.who.int/features/2014/ebola-myths/en/" target="_blank">Ebola isn't contagious until symptoms begin</a>, and it spreads through direct contact with the bodily fluids of patients. It is not, from what we know of the science so far, an airborne virus. So contact with the patient's sweat, blood, vomit, feces or semen could cause infection, and the body remains infectious after death. Much of the spread in west Africa has been attributed to the initial distrust of medical staff, leaving many to be treated at home by loved ones, poorly equipped medics catching the disease from patients, and the traditional burial rites involving manually washing of the dead body. From what we know already, you can't catch it from the air, you can't catch it from food, you can't catch it from water.

Cancelling all flights from west Africa would stop the spread of Ebola

This actually has pretty serious implications. British Airways suspended its four-times-weekly flights to Liberia and Sierra Leone until the end of March, the only direct flight to the region from the UK. In practice, anyone can just change planes somewhere else and get to Britain from Europe, north Africa, or the Middle East. And aid agencies say that flight cancellations are hampering efforts to get the disease under control, they rely on commercial flights to get to the infected regions. Liberia's information minister, Lewis Brown, told the Telegraph this week that BA was putting more people in danger. "We need as many airlines coming in to this region as possible, because the cost of bringing in supplies and aid workers is becoming prohibitive," <a href="http://www.telegraph.co.uk/news/worldnews/ebola/11148672/Liberia-attacks-British-Airways-for-suspending-flights-to-Ebola-hit-country.html" target="_hplink">he told the Telegraph.</a> "There just aren't enough seats on the planes. I can understand BA's initial reaction back in August, but they must remember this is a global fight now, not just a west African one, and we can't just be shut out." Christopher Stokes, director of MSF in Brussels, agreed: “Airlines have shut down many flights and the unintended consequence has been to slow and hamper the relief effort, paradoxically increasing the risk of this epidemic spreading across countries in west Africa first, then potentially elsewhere. We have to stop Ebola at source and this means we have to be able to go there.”

Temperature screening at airports is an effective way to stop those who have the disease from travelling

The screening process is pretty porous, especially when individuals <i>want</i> to subvert it. Wake up on the morning of your flight, feel a bit hot, and you definitely don't want to be sent to an isolation booth for days and have to miss your flight. Take an ibuprofen and you can lower your temperature enough to get past the scanners. And if you suspect you have Ebola, you might be desperate to leave, seeing how much better the treatment success has been in western nations. And experts have warned that you cannot expect people to be honest about who they have had contact with. Thomas Eric Duncan, the Ebola victim who died in Texas, <a href="http://www.latimes.com/nation/la-na-ebola-questions-20141007-story.html#page=1" target="_hplink">told officials he had not been in contact with anyone with the disease</a>, but had in fact visited someone in the late stages of the virus, though he said he believed it was malaria. The extra screening that the US implemented since his death probably wouldn't have singled out Duncan when he arrived from hard-hit Liberia last month, because he had no symptoms while travelling.

Border staff should stop people coming in to the country who are at risk

They're not doctors, and it's a monumental task to train 23,500 people who work for the UK Border Agency how to correctly diagnose a complex disease, and spot it in the millions of people who come through British transport hubs. Public Health England has provided UK Border Force with advice on the assessment of an unwell patient on entry to UK, but they can't be expected to check everyone.

Screening at British airports should be implemented to stop unwell people coming in from affected areas

As mentioned before, the UK, especially London, is a major transport hub. Unlike the US, most of those coming from west Africa will have crossed through Europe, so infected people could be coming from practically anywhere, not just flights directly from those countries. This would require the UK to screen every returning traveller, as people could return to the UK from an affected country through any port of entry. This would be huge numbers of low risk people, at vast, vast expense.

Love HuffPost? Become a founding member of HuffPost Plus today.

This article originally appeared on HuffPost.